Skip to main content

Brian Cheng

Analyst

JP Morgan

Equibles does not estimate personal net worth.

About Brian Cheng

Brian Cheng is recorded as Analyst at JP Morgan. Brian Cheng has spoken on 12 earnings calls across 8 companies, most recently for Coherus Oncology, Inc. on November 9, 2026. Those appearances were for Coherus Oncology, Inc. (CHRS), Kymera Therapeutics, Inc. (KYMR), Ptc Therapeutics, Inc. (PTCT), Absci Corp (ABSI), Tg Therapeutics, Inc. (TGTX) and 3 other companies. The companies whose calls Brian Cheng spoke on are classified in the Healthcare sector.

Brian Cheng on recent calls

“Just building on the previous question here, as we think about the guided development app and second-line ESCC for Tecmo and Tori, you know, how should we think about the potential setup of a study?”
Analyst — J.P. Morgan, Q3 2026 Coherus Oncology, Inc. Earnings Conference Call ·
“Maybe just on pricing negotiations here in next U.S. regions, you know, can you give us an update on the final pricing agreement that will come soon in Germany and also other countries like France and Spain?”
Analyst — J.P. Morgan, PTC 3rd Quarter 2026 Financial Results ·
“Maybe just to start off, we noticed that your indication on your press release is now defined as pattern hair loss. And I think in the prior communication, you have been indicating that the lead indication as androgenetic alopecia.”
Analyst — JPMorgan, Absci Second Quarter 2026 Business Update and Financial and Operating Results Conference Call ·
“Maybe just to start off on Lactorsi, you know, you guys have got a 10 to 15% quarterly growth here.”
Analyst — JP Morgan, Q2 2026 Coherus Oncology, Inc. Earnings Conference Call ·
“Just want to touch on the broaden to OLE portion. Can you give us some color on the latest there? how is the rollover rate looking, and are patients allowed to dose adjust across the three doses in the OLE?”
Analyst — JPMorgan, Kymera Therapeutics, Inc. Q2 FY2026 Earnings Call ·

Affiliation history

  • JP Morgan

    Analyst

    Source not stated

    Current

Company network

ASCENTAGE

Biotechnology · Healthcare

1 appearance Latest appearance 2026-03-26

Recent activity